全文获取类型
收费全文 | 222859篇 |
免费 | 29693篇 |
国内免费 | 7617篇 |
专业分类
耳鼻咽喉 | 1767篇 |
儿科学 | 2018篇 |
妇产科学 | 5401篇 |
基础医学 | 17257篇 |
口腔科学 | 2215篇 |
临床医学 | 18059篇 |
内科学 | 20462篇 |
皮肤病学 | 1491篇 |
神经病学 | 1104篇 |
特种医学 | 6975篇 |
外国民族医学 | 272篇 |
外科学 | 31004篇 |
综合类 | 29405篇 |
现状与发展 | 39篇 |
一般理论 | 3篇 |
预防医学 | 11133篇 |
眼科学 | 191篇 |
药学 | 16075篇 |
154篇 | |
中国医学 | 5429篇 |
肿瘤学 | 89715篇 |
出版年
2024年 | 742篇 |
2023年 | 4602篇 |
2022年 | 9053篇 |
2021年 | 11863篇 |
2020年 | 11050篇 |
2019年 | 9972篇 |
2018年 | 9477篇 |
2017年 | 10031篇 |
2016年 | 10806篇 |
2015年 | 12454篇 |
2014年 | 17916篇 |
2013年 | 17637篇 |
2012年 | 14458篇 |
2011年 | 14822篇 |
2010年 | 10791篇 |
2009年 | 10971篇 |
2008年 | 11279篇 |
2007年 | 10657篇 |
2006年 | 9507篇 |
2005年 | 7864篇 |
2004年 | 6437篇 |
2003年 | 5429篇 |
2002年 | 4579篇 |
2001年 | 4172篇 |
2000年 | 3456篇 |
1999年 | 2943篇 |
1998年 | 2468篇 |
1997年 | 2173篇 |
1996年 | 1775篇 |
1995年 | 1645篇 |
1994年 | 1344篇 |
1993年 | 1055篇 |
1992年 | 920篇 |
1991年 | 853篇 |
1990年 | 646篇 |
1989年 | 587篇 |
1988年 | 514篇 |
1987年 | 434篇 |
1986年 | 350篇 |
1985年 | 465篇 |
1984年 | 388篇 |
1983年 | 250篇 |
1982年 | 273篇 |
1981年 | 268篇 |
1980年 | 216篇 |
1979年 | 155篇 |
1978年 | 105篇 |
1977年 | 83篇 |
1976年 | 76篇 |
1975年 | 50篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
胃癌腹腔脱落细胞检查及临床意义 总被引:1,自引:0,他引:1
腹膜转移是胃癌常见的转移形式。为在肉眼可见转移前发现亚临床的转移现象,自1981年3月至1982年4月,我们共对胃癌病人142例进行了腹腔脱落细胞检查及临床随诊,发现有腹腔脱落细胞阳性者76例(53.5%)。5年随诊结果发现,腹腔脱落细胞阳性者无一例生存>3年;而腹腔脱落细胞阴性的66例中生存5年者有11例。可见,腹腔脱落细胞检查,对胃癌的诊断,治疗和预后判断有一定价值。 相似文献
102.
S. V. Litvinov T. F. Malivanova Yu. V. Chuev I. N. Kryukova 《Bulletin of experimental biology and medicine》1988,105(4):573-575
All-Union Oncologic Scientific Center, Academy of Medical Sciences of the USSR, Moscow. (Presented by Academician of the Academy of Medical Sciences of the USSR N. N. Trapeznikov.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 105, No. 4, pp. 475–477, April, 1988. 相似文献
103.
Staffan Eksborg Lennart Hardell Nils-Olof Bengtsson Marie Sjödin Birgitta Elfsson 《Medical oncology (Northwood, London, England)》1992,9(2):75-80
Sixty women with breast cancer (mean age: 61 years; range 36-78 years) were treated with Epirubicin (4’epi-Dox-orubicin),
60 mg m-2 , as single drug therapy. The drug was administered as 2 hours’ constant rate infusions. The pharmacokinetics of the drug
during the first course of treatment was evaluated by measurements of the plasma concentration of Epirubicin at the end of
the infusion period.
There was a five-fold inter-individual variation of the dose-normalized maximum plasma concentration, which increased with
increasing age of the patients. There was no correlation between this pharmacokinetic parameter and degree of obesity. 相似文献
104.
PROSTATE-SPECIFIC ANTIGEN AS A TUMOR MARKER IN PROSTATE CANCER 总被引:3,自引:0,他引:3
Manabu Kuriyama 《International journal of urology》1994,1(2):99-113
105.
R. A. Gardiner 《ANZ journal of surgery》1995,65(5):350-358
The principles of urology and all surgical disciplines were, not too long ago, considered to be rigidly and permanently established. In this exciting era of change, the foundations of urology are now set on shifting sands rather than the bedrock of the past. The pertinent issue clinically is making discriminating evaluations of new developments so that, where appropriate. they are able to be incorporated into treatment practices to improve patient care. In this overview, a personal appreciation of the more important practical and conceptual changes relating to prostatic. urothelial and renal carcinoma during the past 5 to 10 years is presented. 相似文献
106.
E. Rigotti G. L. Piacentini M. Ress R. Pigozzi A. L. Boner D. G. Peroni 《Clinical and experimental allergy》2006,36(5):614-618
BACKGROUND: Precise relationship between breastfeeding and infant allergy is poorly understood. Objective Aim was to quantify TGF-beta(1) and IL-10 in colostrum and mature milk from allergic and non-allergic mothers and to verify relationship with allergic disease development. METHODS: Mothers (13 allergics, nine controls) of 22 newborns participated to prospective study on development of children atopy. Colostrum and mature milk were assayed for TGF-beta(1) and IL-10 by ELISA. Children underwent paediatrician evaluation at 6 months of life. RESULTS: Data are presented as median values and range. A significant difference in concentration of TGF-beta(1) between colostrum (330, range 0-3400 pg/mL) and mature milk (215, range 0-2400 pg/mL) was observed in samples from allergic mothers (P=0.015). In mature milk TGF-beta(1) was significantly lower in allergic (215, range 0-2400 pg/mL) than in non-allergic mothers (1059, range 0-6250 pg/mL) (P=0.015). IL-10 was weakly expressed without significant differences between allergic (4.8, range 0-42 and 9.5, range 0-42 pg/mL in colostrum and in mature milk) and non-allergic mothers (0, range 0-42 pg/mL in colostrum and 0, range 0-42 pg/mL in mature milk). After 6 months 46% infants from allergic mothers, but none from controls, presented atopic dermatitis. CONCLUSION: TGF-beta(1) was significantly less secreted in mature milk of allergic mothers, while no difference in IL-10 was found. Particular cytokine patterns in milk could influence development of atopic diseases. Further immunological studies in this field are necessary. 相似文献
107.
支气管动脉灌注化疗联合直线加速器放射治疗Ⅲa期非小细胞肺癌 总被引:1,自引:1,他引:0
目的 研究支气管动脉灌注化疗联合直线加速器放射治疗Ⅲa期非小细胞肺癌 (NSCLC)的可行性及临床价值。方法 76例NSCLC患者随机分成A、B 2组 ,A组先行 2次支气管动脉灌注化疗 (BAI) ,第 2次BAI 1~ 2周后再行直线加速器放射治疗 (RT) ;B组单纯行 2次BAI (对照组 )。结果 临床疗效 ,A组 (BAI RT)和B组 (BAI)分别为 89.47%和 60 .5 3% (Ρ <0 .0 1) ;1、3年生存率 ,A、B组分别为 81.5 8%、5 0 .0 0 %和 60 .5 3%、2 1.0 5 % ( 0 .0 1<Ρ <0 .0 5 )。结论 支气管动脉灌注化疗联合直线加速器放射治疗Ⅲa期非小细胞肺癌的临床疗效和患者 1、3年生存率均显著提高 相似文献
108.
Specific receptors for bombesin/gastrin releasing peptide (GRP) on the androgen-independent human prostate cancer cell lines PC-3 and DU-145 were characterized. No specific binding of 125I-[Tyr4]-bombesin to the androgen-dependent human prostate cancer cell line LNCaP was detectable. The binding of 125I-[Tyr4]-bombesin to PC-3 and DU-145 cells was found to be time- and temperature-dependent, saturable, and reversible. Scatchard analysis revealed a single class of binding sites with high affinity (Kd 9.8 × 10?11 M for PC-3, and 9.1 × 10-11 M for DU-145 cells at 25°C) and with a binding capacity of 44,000 binding sites/cell and 19,000 binding sites/cell, respectively. Bound 125I-[Tyr4]-bombesin was rapidly internalized by PC-3 cells. The nonhydrolyzable GTP analog GTP-gamma-S caused a dose-dependent inhibition of 125I-[Tyr4]-bombesin binding to PC-3 and DU-145 cells, indicating that a G-protein (guanine nucleotide-binding protein) couples the bombesin receptor to intracellular effector systems. Bombesin and GRP(14-27) inhibited the binding of 125I-[Tyr4]-bombesin to both cell lines in a dose-dependent manner with inhibition constants (Ki of 0.5 nM and 0.4 nM, respectively. Both cell lines express the bombesin/GRP preferring bombesin receptor subtype, since, in displacement studies, neuromedin B was more than 200 times less potent than bombesin and GRP(14-27) in inhibiting the binding of 125I-[Tyr4]-bombesin. Two synthetic bombesin/GRP antagonists, RC-3095 and RC-3110, powerfully inhibited the specific binding of 125I-[Tyr4]-bombesin with Ki 0.92 nM and 0.26 nM on PC-3 cells, and 3.3 nM and 0.89 nM on DU-145 cells, respectively. These findings indicate that the PC-3 and DU-145 human prostate cancer cell lines possess specific high-affinity receptors for bombesin/GRP, and are suitable models for the evaluation of the antineoplastic activity of new bombesin/GRP antagonists in the treatment of androgen-independent prostate cancer. © 1994 Wiley-Liss, Inc. 相似文献
109.
W. de Riese E. B. Walker C. de Riese T. M. Ulbright W. N. Crabtree J. Messemer J. A. Jones A. Hinkel R. S. Foster J. P. Donohue T. Senge 《Urological research》1994,22(4):213-220
Current clinical staging, which includes the use of serum tumor markers and imaging techniques, fails to identify the 30–40% of clinical stage I (CS I) nonseminomatous germ cell testicular tumor (NSGCT) patients who have occult metastatic disease. Therefore, there is a real clinical need to evaluate new biological parameters of the primary tumor that might be useful as predictors of occult metastatic disease. This study was undertaken to compare quantitative DNA measurements by flow cytometry and image analysis in CS I NSGCT, and to analyze the relevance of these parameters for predicting occult lymph node involvement. Different blocks of formalin-fixed, paraffin-embedded NSGCTs of 62 CS I patients who underwent retroperitoneal lymph node dissection between 1985 and 1989 were prepared according to the Hedley technique, and analyzed by quantitative cytometry. Thirty-six (58.1%) patients had histologically proven lymph node involvement (pathological stage II), whereas 26 (41.9%) patients (pathological stage I) had neither lymph node metastases according to retroperitoneal lymph node dissection (RPLND) specimens nor tumor recurrence during follow-up. Concordant results were found in 76.5% of the samples by both cytometric techniques. For flow cytometry, the percentages of aneuploid cells in the S- and the G2M+S-phase were the most robust predictive parameters for lymph node involvement, whereas for image analysis the 5c exceeding rate (5cER) had the most predictive significance. Based on the experience obtained in this study, both cytometric techniques provide additional information on tumor aggressiveness that might be useful in therapeutic selection of early stage NSGCT patients for either RPLND or surveillance only. 相似文献
110.
乳腺囊性增生病癌变过程中部分因素变化的意义 总被引:3,自引:0,他引:3
检测乳腺囊性增生病(FCD)经不典型增生到癌变部分因素的变化。结果提示:从因明显FCD症状活检至癌变为2~10年;从Ⅱ级以上不典型增生到临床癌变需2~7年;癌变率为3.1%。FCD患者存在性激素分泌调控失常,血浆雌激素和催乳素含量增加,导致上皮细胞增生。乳腺一般性增生细胞的DNA含量和超微结构与正常乳腺上皮细胞相似;无肿瘤相关抗原及异常基因产物表达。而发生在一般性增生基础上的不典型增生则呈现细胞基因物质DNA含量增加,部分为超4C的多倍体细胞;同时出现细胞膜和细胞核超微结构异常;雌激素受体含量增加,对性激素的依赖性和敏感性增强;部分不典型增生细胞出现胚胎性肿瘤相关抗原和异常基因产物表达。随不典型增生程度加重至乳腺癌,上述诸因素的变化趋势具有明显规律性。提示FCD上皮细胞从一般性增生经不典型增生至乳腺癌为细胞生物学连续逐渐变化的过程。部分不典型增生细胞中具有癌倾向的细胞生物学行为异常和表型变化与乳腺癌发生密切相关。细胞核DNA含量等异常变化及程度可作为乳腺癌前病变发展程度的客观标志 相似文献